ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638309 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638309; 2) Community: the network communities that were significantly associated with the response to NSC 638309; 3) Molecule: the relationships between components within communities and NSC 638309; 4) MDR: the compounds that were significantly associated with the NSC 638309.

NSC Compound Enrichment Correlation
NSC 750717 5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one 0.00957309511256283 0.28825038
NSC 751902 2-4-[5-(3,4-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,7-dimethoxy-1,3-benzothiazole 0.00957309511256283 0.058130008
NSC 657446 Thiazolo[2,3-b]thiazolium, 2,3-dihydro- 2-[(2-methoxyphenyl)methylene]- 5-(3-nitrophenyl)-3-oxo-, chloride 0.00995118568011489 0.4837486
NSC 666388 Null 0.00995118568011489 0.52727003
NSC 699671 Null 0.00995118568011489 0.48720122
NSC 105014 Cladribine 0.0105244982742819 0.32408285
NSC 132313 Dianhydrogalactitol 0.0105244982742819 0.426044
NSC 144126 Null 0.0105244982742819 0.093308503
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0105244982742819 0.32155504
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0105244982742819 0.43199427
Total:109  Current:27    [First] [Prev] [Next] [Last]